Overview

Safety Study of TRK-820 for Patient With Hemodialysis

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to observe pharmacokinetics and safety of nalfurafine hydrochloride in patients receiving hemodialysis.
Phase:
Phase 1
Details
Lead Sponsor:
SK Chemicals Co., Ltd.
SK Chemicals Co.,Ltd.
Collaborator:
Toray Industries, Inc